Sage Journals: Discover world-class research

Abstract

Background:

Patients with different hypertension status could potentially respond differently to the treatment of clopidogrel-aspirin owing to thrombosis, antiplatelet resistance, and platelet reactivity.

Aims:

The aim of the study is to examine the efficacy and safety of clopidogrel-aspirin in patients with mild ischemic stroke or high-risk transient ischemic attack (TIA) according to different hypertension status.

Methods:

In the Intensive Statin and Antiplatelet Therapy for Acute High-Risk Intracranial or Extracranial Atherosclerosis (INSPIRES) trial, patients were randomized to either clopidogrel-aspirin or aspirin group. The primary outcome was any new ischemic or hemorrhagic stroke within 90 days. Hypertension status was classified into two categories based on medical history: patients with or without hypertension.

Results:

Among 6100 patients with complete data of hypertension status, 3915 (64.2%) were men. Clopidogrel-aspirin compared with aspirin was associated with reduced incidence of new stroke in patients without hypertension (hazard ratio (HR): 0.62, 95% confidence interval (CI): 0.44−0.86, p = 0.004), but not in patients with hypertension (HR: 0.87, 95% CI: 0.71−1.07, p = 0.18; p = 0.085 for interaction).

Conclusions:

In this study, patients without hypertension may have more benefit from receiving treatment with clopidogrel-aspirin than those with hypertension. This finding can be used as an enrichment strategy in the future secondary stroke prevention randomized clinical trials of dual antiplatelet therapy.

Trial Registration:

The INSPIRES trial was registered at http://www.clinicaltrials.gov (unique identifier: NCT03635749).

Keywords

Stroke transient ischemic attack atherosclerosis clopidogrel-aspirin hypertension

Get full access to this article

View all access options for this article.

References

Cho

Kim

Koo

, et al. Untreated hypertension and prognosis paradox in acute ischemic stroke. Neurol Sci 2023; 44: 2087–2095.

Gaciong

Siński

Lewandowski

Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analyses. Curr Hypertens Rep 2013; 15: 559–574.

Cipolla

Liebeskind

Chan

SL.

The importance of comorbidities in ischemic stroke: impact of hypertension on the cerebral circulation. J Cereb Blood Flow Metab 2018; 38: 2129–2149.

Buonacera

Stancanelli

Malatino

Stroke and hypertension: an appraisal from pathophysiology to clinical practice. Curr Vasc Pharmacol 2019; 17: 72–84.

Wang

Meng

Tian

, et al. Effect of hypertension on efficacy and safety of ticagrelor-aspirin versus clopidogrel-aspirin in minor stroke or transient ischemic attack. Stroke 2022; 53: 2799–2808.

Zhou

Cai

GJ.

From hypertension to stroke: mechanisms and potential prevention strategies. CNS Neurosci Ther 2011; 17: 577–584.

Wang

Zhao

, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013; 369: 11–19.

De Havenon

Johnston

Easton

, et al. Evaluation of systolic blood pressure, use of aspirin and clopidogrel, and stroke recurrence in the platelet-oriented inhibition in new TIA and minor ischemic stroke trial. JAMA Netw Open 2021; 4: e2112551.

Gao

Chen

Pan

, et al. Dual antiplatelet treatment up to 72 hours after ischemic stroke. N Engl J Med 2023; 389: 2413–2424.

10.

Gao

Pan

Han

, et al. Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclerosis (INSPIRES). Stroke Vasc Neurol 2023; 8: 249–258.

11.

Whelton

Carey

Aronow

, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018; 71: e127–e248.

12.

Tao

, et al. Different levels of blood pressure, different benefit from dual antiplatelet therapy in minor stroke or TIA patients. Sci Rep 2017; 7: 3884.

13.

Willmot

Leonardi-Bee

Bath

PM.

High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 2004; 43: 18–24.

14.

Wangqin

Wang

, et al. Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial. Stroke Vasc Neurol 2017; 2: 176–183.

15.

Kleindorfer

Towfighi

Chaturvedi

, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke 2021; 52: e483–e484.

16.

Turan

Cotsonis

Lynn

, et al. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation 2007; 115: 2969–2975.

17.

Panza

Quyyumi

Brush

Jr , et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22–27.

18.

Boulanger

CM.

Secondary endothelial dysfunction: hypertension and heart failure. J Mol Cell Cardiol 1999; 31: 39–49.

19.

Poli

Tofler

Larson

, et al. Association of blood pressure with fibrinolytic potential in the Framingham offspring population. Circulation 2000; 101: 264–269.

20.

Carrim

Neves

, et al. Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies. Thromb J 2016; 14: 29.

21.

Redfors

Chen

Ben-Yehuda

, et al. Association between hypertension, platelet reactivity, and the risk of adverse events after percutaneous coronary intervention (from the ADAPT-DES study). Am J Cardiol 2019; 124: 1380–1388.

22.

Akturk

Caglar

Erturk

, et al. Hypertension as a risk factor for aspirin and clopidogrel resistance in patients with stable coronary artery disease. Clin Appl Thromb Hemost 2014; 20: 749–754.

23.

Ozben

Tanrikulu

Ozben

Caymaz

Aspirin resistance in hypertensive patients. J Clin Hypertens (Greenwich) 2010; 12: 714–720.

24.

Kim

Lee

Han

, et al. Prevalence and risk factors for aspirin and clopidogrel resistance in patients with coronary artery disease or ischemic cerebrovascular disease. Ann Clin Lab Sci 2009; 39: 289–294.

25.

Ball

STE

Taylor

McCollum

CN.

Resistance to antiplatelet therapy is associated with symptoms of cerebral ischemia in carotid artery disease. Vasc Endovascular Surg 2020; 54: 712–717.

26.

Kahraman

Sahin

Kilic

, et al. The frequency of aspirin resistance and its risk factors in patients with metabolic syndrome. Int J Cardiol 2007; 115: 391–396.

27.

Blann

Naqvi

Waite

, et al. von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens 1993; 7: 107–111.

28.

Bath

Chalmers

Powers

, et al. International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens 2003; 21: 665–672.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.56 MB

Effect of history of hypertension on efficacy of clopidogrel-aspirin in ischemic stroke

Abstract

Background:

Aims:

Methods:

Results:

Conclusions:

Trial Registration:

Keywords

Get full access to this article

References

Supplementary Material